Literature DB >> 16760924

N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors.

Silvia Marinelli1, Vincenzo Di Marzo, Fulvio Florenzano, Filomena Fezza, Maria Teresa Viscomi, Mario van der Stelt, Giorgio Bernardi, Marco Molinari, Mauro Maccarrone, Nicola B Mercuri.   

Abstract

In the present study, we used electrophysiological, biochemical, and confocal microscopy techniques, to investigate the functional role of transient receptor potential vanilloid type 1 (TRPV1) and cannabinoid type 1 receptors (CB1-R) in the substantia nigra pars compacta (SNpc) and their stimulation by the endocannabinoid N-arachidonoyl-dopamine (NADA). Liquid chromatography-mass spectrometry analyses revealed that a NADA-like compound is produced in substantia nigra slices, in conditions of hyperactivity. Moreover, the functional role of both TRPV1 and CB1-R in modulating synaptic transmission in this area was suggested by confocal microscopy data, showing TRPV1 and CB1-R immunoreactivity in punctate structures, probably representing synaptic contacts on cell bodies of the SNpc. In patch-clamp recordings from dopamine (DA) neurons of the SNpc, we found that NADA increases or reduces glutamatergic transmission onto DA neurons by activating TRPV1 and CB1 receptors, respectively, whereas it decreases GABAergic transmission via CB1 stimulation. Facilitation of glutamate release through TRPV1 was blocked in the presence of a selective blocker of the putative endocannabinoid membrane transporter (EMT), indicating that NADA needs to be taken up by cells to interact with this receptor. In line with these data, biochemical results demonstrated that NADA selectively acted at CB1-R when its re-uptake was blocked. Altogether these data demonstrate a significant role exerted by the endocannabinoid/endovanilloid NADA in the regulation of synaptic transmission to DA neurons of the SNpc. Moreover, they highlight a key function of the EMT transporter in promoting the stimulation of TRPV1 or CB1-R, thus favoring facilitation or inhibition of glutamate synaptic release.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760924     DOI: 10.1038/sj.npp.1301118

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  50 in total

1.  Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse.

Authors:  Salvatore Lecca; Miriam Melis; Antonio Luchicchi; Anna Lisa Muntoni; Marco Pistis
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  TRPV1: a stress response protein in the central nervous system.

Authors:  Karen W Ho; Nicholas J Ward; David J Calkins
Journal:  Am J Neurodegener Dis       Date:  2012-04-01

Review 3.  N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Authors:  Mark Connor; Chris W Vaughan; Robert J Vandenberg
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 4.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

5.  TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.

Authors:  Helen E Gibson; Jeffrey G Edwards; Rachel S Page; Matthew J Van Hook; Julie A Kauer
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

6.  Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT.

Authors:  Andrew J Gilmore; Marika Heblinski; Aaron Reynolds; Michael Kassiou; Mark Connor
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

7.  A putative 'pre-nervous' endocannabinoid system in early echinoderm development.

Authors:  G A Buznikov; L A Nikitina; V V Bezuglov; M E Y Francisco; G Boysen; I N Obispo-Peak; R E Peterson; E R Weiss; H Schuel; B R S Temple; A L Morrow; J M Lauder
Journal:  Dev Neurosci       Date:  2009-11-12       Impact factor: 2.984

8.  Loss of interneuron LTD and attenuated pyramidal cell LTP in Trpv1 and Trpv3 KO mice.

Authors:  Travis E Brown; Anda M Chirila; Benjamin R Schrank; Julie A Kauer
Journal:  Hippocampus       Date:  2013-06-03       Impact factor: 3.899

Review 9.  Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

Authors:  K Rea; M Roche; D P Finn
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 10.  The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1).

Authors:  Sara L Morales-Lázaro; Sidney A Simon; Tamara Rosenbaum
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.